Skip to content
TrialScanner

NCT05261191

A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy

Phase 1CompletedMGNXLead

Registry record

Lead sponsor
MacroGenics
Conditions
Human Immunodeficiency Virus I Infection; Immunodeficiency Virus Type 1, Human; Human Immunodeficiency Virus Type 1
Primary completion
May 29, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05261191 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05261191: A Study of MGD020 Alone or... | TrialScanner